Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes for COPD pharmacological trials: from lung function to biomarkers.
Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, Jones PW, Mahler DA, Make B, Miravitlles M, Page CP, Palange P, Parr D, Pistolesi M, Rennard SI, Rutten-van Mölken MP, Stockley R, Sullivan SD, Wedzicha JA, Wouters EF; American Thoracic Society; European Respiratory Society Task Force on outcomes of COPD. Cazzola M, et al. Among authors: palange p. Eur Respir J. 2008 Feb;31(2):416-69. doi: 10.1183/09031936.00099306. Eur Respir J. 2008. PMID: 18238951 Free article. Review.
Project PriMo: sharing principles and practices of bronchodilator therapy monitoring in COPD: a consensus initiative for optimizing therapeutic appropriateness among Italian specialists.
Cazzola M, Brusasco V, Centanni S, Cerveri I, De Michele F, Di Maria G, Palange P, Pellegrino R, Polverino M, Rossi A, Papi A. Cazzola M, et al. Among authors: palange p. Pulm Pharmacol Ther. 2013 Apr;26(2):218-28. doi: 10.1016/j.pupt.2012.10.010. Epub 2012 Nov 10. Pulm Pharmacol Ther. 2013. PMID: 23147424
Onset of action of formoterol versus salmeterol via dry powder inhalers in moderate chronic obstructive pulmonary disease: a randomized, placebo-controlled, double-blind, crossover study.
Cazzola M, Paggiaro P, Palange P, Bjermer L, Ausin P, Carlsson LG, Ekelund J, Lotvall J. Cazzola M, et al. Among authors: palange p. Clin Drug Investig. 2012 Mar 1;32(3):147-55. doi: 10.2165/11630880-000000000-00000. Clin Drug Investig. 2012. PMID: 22235841 Clinical Trial.
Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.
Puente-Maestu L, Palange P, Casaburi R, Laveneziana P, Maltais F, Neder JA, O'Donnell DE, Onorati P, Porszasz J, Rabinovich R, Rossiter HB, Singh S, Troosters T, Ward S. Puente-Maestu L, et al. Among authors: palange p. Eur Respir J. 2016 Feb;47(2):429-60. doi: 10.1183/13993003.00745-2015. Epub 2016 Jan 21. Eur Respir J. 2016. PMID: 26797036 Free article. Review.
COPD: a multifactorial systemic disease.
Huertas A, Palange P. Huertas A, et al. Among authors: palange p. Ther Adv Respir Dis. 2011 Jun;5(3):217-24. doi: 10.1177/1753465811400490. Epub 2011 Mar 23. Ther Adv Respir Dis. 2011. PMID: 21429981 Free article. Review.
Measuring habitual physical activity in adults with cystic fibrosis.
Savi D, Quattrucci S, Internullo M, De Biase RV, Calverley PM, Palange P. Savi D, et al. Among authors: palange p. Respir Med. 2013 Dec;107(12):1888-94. doi: 10.1016/j.rmed.2013.09.012. Epub 2013 Sep 22. Respir Med. 2013. PMID: 24094944 Free article.
209 results